Leaderboards/Sarcoidosis and Beryllium Toxicity Research

Sarcoidosis and Beryllium Toxicity Research

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Tianhe Sun
Sunesis (United States)
2
Vivienne Kahlmann
Erasmus MC
3
Hanna‐Kaisa Nordenswan
University of Helsinki
4
Yuyi Liu
Hainan University
5
Mingyao Wang
Ministry of Education
6
Maria Chianese
University of Trieste
7
Melina Gade Sikjær
Lillebaelt Hospital
8
Julie K. Shade
EOSPACE (United States)
9
Zhujie Cao
Chinese Academy of Medical Sciences & Peking Union Medical College
10
Jing Liu
Obstetrics and Gynecology Hospital of Fudan University

Rising Stars Papers

1
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
Pharmaceuticals|2024
88 cit.
2
First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate
New England Journal of Medicine|2025
54 cit.
3
Isoform-selective TGF-β3 inhibition for systemic sclerosis
Med|2024
26 cit.
4
Flavonoid-rich extract of Paederia scandens (Lour.) Merrill improves hyperuricemia by regulating uric acid metabolism and gut microbiota
Food Chemistry|2025
16 cit.
5
Socioeconomic inequalities in human papillomavirus knowledge and vaccine uptake: evidence from a cross-sectional study in China
Frontiers in Public Health|2024
10 cit.
6
Bioaffinity ultrafiltration combined with UPLC-ESI-QTrap-MS/MS for screening of xanthine oxidase inhibitors from Paederia foetida L. leaves
Arabian Journal of Chemistry|2024
8 cit.
7
Clinical significance of serum lactate dehydrogenase combined with a multivariate model for predicting the near-term outcome of primary nasopharyngeal carcinoma
Life Sciences|2024
5 cit.
8
Risk of depression and anxiety in 7.302 patients with sarcoidosis: a nationwide cohort study.
PubMed|2024
3 cit.
9
Optimization of ultrasonic extraction of bioactive components from Alpiniae oxyphyllae Fructus using response surface methodology
Journal of Applied Research on Medicinal and Aromatic Plants|2024
3 cit.
10
Methotrexate Versus Prednisone as First-Line Treatment for Pulmonary Sarcoidosis: The PREDMETH Trial
American Journal of Respiratory and Critical Care Medicine|2025
2 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Abha Pandey
Banaras Hindu University
2
Marcel Veltkamp
University Medical Center Utrecht
3
Rishi Patel
Texas Tech University
4
Beckley K. Davis
Franklin & Marshall College
5
Josep Ángel Bosch
Universitat Autònoma de Barcelona
6
Anoop M. Nambiar
The University of Texas at San Antonio Health Science Center
7
Barbara Ruaro
University of Trieste
8
Agnes W. Boots
Maastricht University
9
Monika Žůrková
University Hospital Olomouc
10
Jawad H. Butt
Copenhagen University Hospital

Emerging Leaders Papers

1
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
EBioMedicine|2023
256 cit.
2
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
European Heart Journal|2023
239 cit.
3
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction
Annals of Internal Medicine|2022
150 cit.
4
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
Circulation|2022
150 cit.
5
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
European Journal of Heart Failure|2022
96 cit.
6
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
Pharmaceuticals|2024
88 cit.
7
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
Journal of the American College of Cardiology|2022
80 cit.
8
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
Journal of Clinical Medicine|2022
67 cit.
9
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction
Journal of the American College of Cardiology|2022
46 cit.
10
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction
Journal of the American College of Cardiology|2024
44 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Richard A. Watts
University of East Anglia
2
Ronald G. Crystal
Cornell University
3
J. Charles Jennette
University of North Carolina at Chapel Hill
4
Marjolein Drent
Maastricht University
5
Gene G. Hunder
Mayo Clinic
6
Anthony S. Fauci
Georgetown University
7
Vincent Cottin
Université Claude Bernard Lyon 1
8
Marc A. Judson
Cleveland Clinic
9
Markku Kupari
University of Helsinki
10
Leonard H. Calabrese
Cleveland Clinic

Current Senior Leaders Papers

1
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
Arthritis & Rheumatism|1988
19.9k cit.
2
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism|2012
6.6k cit.
3
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Arthritis & Rheumatism|1990
2.5k cit.
4
Coronavirus Infections—More Than Just the Common Cold
JAMA|2020
2.3k cit.
5
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Proceedings of the National Academy of Sciences|1997
2k cit.
6
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
Nature|1993
1.8k cit.
7
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
Science|1986
1.7k cit.
8
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness
The Journal of Infectious Diseases|2008
1.6k cit.
9
Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome
New England Journal of Medicine|1983
1.6k cit.
10
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
The Journal of Experimental Medicine|1986
1.6k cit.

Reagents for Sarcoidosis and Beryllium Toxicity Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

14-3-3 zeta/delta (D7H5) Rabbit Monoclonal Antibody

#7413$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

Oct-4A (C30A3) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Violet 510 Conjugate)

#46570$458
View Evidence →
Cell Signaling TechnologyEvidence 60

CBX7 (E7N1W) Rabbit Monoclonal Antibody

#34547$175,376
View Evidence →
Cell Signaling TechnologyEvidence 65

Whitlow/218 Linker (E3U7Q) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#69310$5,131,466
View Evidence →